Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study.
- DOI
- 10.1016/s0090-8258(03)00413-x
- Published
- 2003 Oct
- Container
- Gynecologic oncology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0090-8258-03-00413-x,
title = {Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study.},
author = {Belpomme D and Krakowski I and Beauduin M and Petit T and Canon JL and Janssens J and Gauthier S and De Pauw A and Moreau V and Kayitalire L},
year = {2003},
journal = {Gynecologic oncology},
doi = {10.1016/s0090-8258(03)00413-x},
url = {https://doi.org/10.1016/s0090-8258(03)00413-x}
}RIS
TY - JOUR TI - Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study. AU - Belpomme D AU - Krakowski I AU - Beauduin M AU - Petit T AU - Canon JL AU - Janssens J AU - Gauthier S AU - De Pauw A AU - Moreau V AU - Kayitalire L PY - 2003 JO - Gynecologic oncology DO - 10.1016/s0090-8258(03)00413-x UR - https://doi.org/10.1016/s0090-8258(03)00413-x ER -
APA
D, B., I, K., M, B., T, P., JL, C., J, J., S, G., A, D. P., V, M., & L, K. (2003). Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II study.. Gynecologic oncology. https://doi.org/10.1016/s0090-8258(03)00413-x
Source records
- pubmed · retrieved 2026-09-27T13:12:16.198Z
- europe-pmc · retrieved 2026-09-27T13:12:16.207Z